Back to Search
Start Over
COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia.
- Source :
-
Internal medicine journal [Intern Med J] 2022 Nov; Vol. 52 (11), pp. 1884-1890. Date of Electronic Publication: 2022 Jul 30. - Publication Year :
- 2022
-
Abstract
- Background: The development of vaccines against SARS-CoV2 has been a key public health response to the COVID-19 pandemic. However, since their introduction, there have been reports of anaphylactic reactions to vaccines in individuals with history of allergic reactions to other vaccines, excipients or to COVID vaccines.<br />Aim: A dedicated adult COVID vaccine allergy clinic with a standardised allergy testing protocol was set up to investigate safety and suitability of available COVID vaccines in Australia.<br />Methods: Patients referred to a state-wide COVID-19 vaccine allergy clinic between March and August 2021 with a history of allergy underwent skin-prick testing and intradermal testing to both available vaccine formulations (BNT162b2 and ChAdOx1-S), excipients (polyethylene glycol and polysorbate 80), excipient-containing medications and controls. Basophil activation testing was conducted in few subjects with convincing history of immediate type reactions.<br />Results: Fifty-three patients underwent testing for possible excipient allergy (n = 19), previous non-COVID vaccine reaction (n = 13) or previous reaction to dose 1 of COVID-19 vaccine (n = 21). Patients were predominantly female (n = 43, 81%), aged 18-83 (median 54) years. Forty-four patients tested negative and 42 of these received at least their first dose of a COVID-19 vaccine. Nine patients tested positive to excipients or excipient-containing medication only (n = 3), or vaccines (n = 6). Five patients were positive to just BNT162b2, 3/5 have been vaccinated with ChAdOx1-S. One who was skin test positive to both vaccines, but negative BAT to ChAdOx1-S was successfully vaccinated with ChAdOx1-S.<br />Conclusion: Even in a high-risk population, most patients can be vaccinated with available COVID-19 vaccines. This paper reports local experiences using a combined allergy testing protocol with skin testing and BAT during the pandemic.<br /> (© 2022 The Authors. Internal Medicine Journal published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Physicians.)
- Subjects :
- Adult
Female
Humans
Male
BNT162 Vaccine
Excipients adverse effects
Pandemics
SARS-CoV-2
South Australia
Vaccination adverse effects
Adolescent
Young Adult
Middle Aged
Aged
Aged, 80 and over
ChAdOx1 nCoV-19
Anaphylaxis etiology
COVID-19 epidemiology
COVID-19 prevention & control
COVID-19 Vaccines adverse effects
COVID-19 Vaccines therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1445-5994
- Volume :
- 52
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Internal medicine journal
- Publication Type :
- Academic Journal
- Accession number :
- 35848521
- Full Text :
- https://doi.org/10.1111/imj.15888